113809 ⎘
Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) D-Amino-acid oxidase (1.4.3.3)
METHODS FOR MAKING L-GLUFOSINATE
#2METHODS FOR MAKING L-GLUFOSINATE
#3METHODS FOR MAKING L-GLUFOSINATE
#4METHODS FOR MAKING L-GLUFOSINATE
#5D-AMINO ACID OXIDASE MUTANT AND APPLICATION THEREOF IN PREPARATION OF L-PHOSPHINOTHRICIN
#6Methods for making L-glufosinate
#7Methods for making L-glufosinate
#8Methods for making L-glufosinate
#9METHOD FOR PREPARING L-GLUFOSINATE AMMONIUM BY BIOLOGICAL ENZYMATIC DE-RACEMIZATION, GLUFOSINATE AMMONIUM DEHYDROGENASE MUTANT AND USE THEREOF
#10Method for asymmetrically preparing L-phosphinothricin by oxidation-reduction reaction through biological multi-enzyme coupling
#11Methods for producing crystalline L-glufosinate ammonium monohydrate
#12Methods for making L-glufosinate
#13D-amino acid oxidative enzyme mutant and application thereof
#14Methods for making L-glufosinate
#15Methods for making L-glufosinate
#16Methods for making L-glufosinate
#17Methods for making L-glufosinate
#18Methods for making L-glufosinate
#19Composition containing polycationic triblock copolymer, polyanionic polymer and physiologically active peptide
#20Processes of producing a fermentation product
#21Mycotoxin-reducing composition
#22Pain treatment
#23Processes of producing a fermentation product
#24MYCOTOXIN-REDUCING COMPOSITION
#25Compositions of variant biocatalysts for preparing enantiopure amino acids
#26RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)
#27RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
#28RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)
#29RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
#30RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)
#31RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)
#32RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
#33Polycationic compositions for cellular delivery of polynucleotides
#34RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
#35RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)
#36Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)
#37Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)
#38RNA interference mediated inhibition of cyclin dependent kinase-2 (CDK2) gene expression using short interfering nucleic acid (siNA)
#39RNA interference mediated inhibition of MAP kinase gene expression or expression of genes involved in MAP kinase pathway using short interfering nucleic acid (siNA)
#40RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)
#41RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)
#42RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)
#43Polycationic compositions for cellular delivery of polynucleotides
#44RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
#45RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)
#46RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acis (siNA)
#47RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)
#48RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)
#49RNA interference mediated inhibition of NF-Kappa B / REL-A gene expression using short interfering nucleic acid (siNA)
#50RNA interference mediated inhibition of GPRA and AAA1 gene expression using short interfering nucleic acid (siNA)
#51RNA interference mediated inhibition of cholinergic muscarinic receptor (CHRM3) gene expression using short interfering nucleic acid (siNA)
#52RNA interference mediated inhibition of protein tyrosine phosphatase type IVA (PRL3) gene expression using short interfering nucleic acid (siNA)
#53RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)
#54RNA interference mediated inhibition of epidermal growth factor receptor (EGFR) gene expression using short interfering nucleic acid (siNA)
#55RNA interference mediated inhibition of cholesteryl ester transfer protein (CEPT) gene expression using short interfering nucleic acid (siNA)
#56RNA interference mediated inhibition of 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)
#57RNA interference mediated inhibition of ADAM33 gene expression using short interfering nucleic acid (siNA)
#58RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)
#59RNA interference mediated inhibition of type 1 insulin-like growth factor receptor gene expression using short interfering nucleic acid (siNA)
#60RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)
#61RNA interference mediated inhibition of chromosome translocation gene expression using short interfering nucleic acid (siNA)
#62RNA interference mediated inhibition of angiopoietin gene expression using short interfering nucleic acid (siNA)
#63RNA interference mediated inhibition of gastric inhibitory polypeptide (GIP) and gastric inhibitory polypeptide receptor (GIPR) gene expression using short interfering nucleic acid (siNA)
#64RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)
#65RNA interference mediated inhibition of proliferating cell nuclear antigen (PCNA) gene expression using short interfering nucleic acid (siNA)
#66RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)
#67RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)
#68RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA)
#69RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)
#70RNA interference mediated inhibition of TRPM7 gene expression using short interfering nucleic acid (siNA)
#71RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)
#72RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)
#73RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)
#74RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
#75RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
#76RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)